HomeNewsBusinessIPOIPO Frenzy: 3 new issues and 11 listings to hit Dalal Street next week

IPO Frenzy: 3 new issues and 11 listings to hit Dalal Street next week

India's solid macroeconomic environment and promising growth prospects create an ideal backdrop for this vibrant IPO market. Next week, three IPOs will open for subscription and Street will see 11 listings.

June 30, 2024 / 23:35 IST
Story continues below Advertisement
In the coming week, the IPOs of Emcure Pharmaceuticals, in which shark tank fame Namita Thapar is the Executive Director and Bansal Wire will open for subscription in the mainboard segment.
In the coming week, the IPOs of Emcure Pharmaceuticals, in which shark tank fame Namita Thapar is the Executive Director and Bansal Wire will open for subscription in the mainboard segment.

The primary market is gearing up for another stellar week as three companies are set to launch their initial public offerings (IPOs) in the upcoming week to raise just over Rs 2,700 crore. With political stability restored, stock markets are once again on the rise, with Nifty and Sensex hitting record highs.

Optimism is especially pronounced in the IPO market, as Hyundai Motor India, the country's second-largest carmaker, is planning a huge Rs 25,000 crore IPO this year, which would be the biggest in India's history.

Story continues below Advertisement

Additionally, India's solid macroeconomic environment and promising growth prospects create an ideal backdrop for this vibrant IPO market. Analysts expect significant capital to be deployed in public markets and strong demand for both new-age and conventional companies in the near-term.

In the coming week, the IPOs of Emcure Pharmaceuticals, in which shark tank fame Namita Thapar is the Executive Director and Bansal Wire will open for subscription in the mainboard segment, while Ambey Laboratories is the sole SME issue.